Liver Fibrosis-Novel Therapy Perspective
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2017, Vol 1, Issue 7
Abstract
Liver fibrosis is highly prevalent in United States. No therapy has been successful to cure it so far. The current approaches in treatment are to prevent its causative etiology such as viral infection, alcohol abuse etc. or liver transplantation. Much progress has been made to understand the mechanisms for development of myofibroblasts in developing fibro genesis, inflammation and cell death. This review summarizes some of the key aspects of liver fibrosis and some novel therapies that have a potential to become a cure.
Authors and Affiliations
Panakanti R*
Keywords
Related Articles
- EP ID EP745878
- DOI 10.23880/oajpr-16000139
- Views 33
- Downloads 0
Determinants of Contraceptive Utilization among Married Women
We studied the literature available on contraceptive methods to check their prevalence and efficiency. Contraceptive methods influence the fertility reduction. Commonly used contraceptive methods include intrauterine de...
CDP-Choline Effect on Arthritis Model in Rat
CDP-choline is a naturally occurring endogenous nucleotide, which after administration rapidly metabolizes to choline (which is a natural α7nAChR selective Agonist) and cytidine/uridine. In the body, Choline promotes sev...
Virtual Screening and Validation of Potential Lead Compound from the Malaria Box against Plasmodium Falciparum S7 and S19 Proteins
Molecular docking is a computer based tool used in drug design, where predominant binding modes of a ligand with known three dimensional protein structures are predicted. This study addresses the possible ways of coming...
Advancements in Analytical Development and Validation: A Comprehensive Review in Pharmaceutical Sciences
The pharmaceutical industry is dedicated to consistently producing high-quality products at an optimal cost, necessitating the development of robust methodologies across various stages from formulation to commercializat...
Recent Advances in Process Development of Antiviral Agents Targeting the Influenza Virus: Amantadine-RemantadineDerived Pharmaceutical Agents
This short review summarizes our work on the process development for the synthesis of amontidine remantadine. The M2 proton channel of the influenza A virus is the target of the anti-influenza drugs amantadine and rimant...